# Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain

> **NCT02568826** · PHASE2 · WITHDRAWN · sponsor: **Indena S.p.A**

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** 3-glycosyl-3-Odemethylthiocolchicine derivative

## Key facts

- **NCT ID:** NCT02568826
- **Lead sponsor:** Indena S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled in the study.
- **Last updated:** 2025-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02568826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02568826, "Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02568826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*